Intermediate-Timed Alemtuzumab May be Associated with Increased Graft Rejection in Reduced-Intensity Bone Marrow Transplant for Sickle Cell Disease

Biol Blood Marrow Transplant
2018
https://researcherprofiles.org/profile/464637064
Krupesh Patel, Shreya Agarwal, Nancy Durning, Melanie Hankewycz, Alfred P. Gillio,
Barbara Adler-Brecher, Jeanette Haugh, Jennifer Krajewski